Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.39%
Change (1 year)
Categories
Sage Therapeutics (SAGE) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $61.79 M
According to Sage Therapeutics 's latest financial reports the company's total liabilities are $61.79 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Sage Therapeutics - Total liabilities on balance sheet (from 2013 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $82.74 M | -20.32% |
| 2022-12-31 | $0.10 B | 7.89% |
| 2021-12-31 | $96.25 M | 10.75% |
| 2020-12-31 | $86.91 M | -37.7% |
| 2019-12-31 | $0.13 B | 55.45% |
| 2018-12-31 | $89.73 M | 64.76% |
| 2017-12-31 | $54.46 M | 51.22% |
| 2016-12-31 | $36.01 M | 135.06% |
| 2015-12-31 | $15.32 M | 96.93% |
| 2014-12-31 | $7.78 M | -80.58% |
| 2013-12-31 | $40.06 M | 144.48% |
| 2012-12-31 | $16.38 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | $9.56 M | -84.53% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $0.32 B | 419.94% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $3.98 B | 6,352.82% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | $0.15 B | 147.22% | 🇺🇸 USA |